US Edition
BioPharma Credit lends to Paratek as it cashes out its OPTN position - QuotedData
Summary by QuotedData
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
BioPharma Credit lends to Paratek as it cashes out its OPTN position - QuotedData
BioPharma Credit highlights yesterday’s announcement that Paratek has completed its purchase of OPTN. In connection with this, BioPharma Credit received $82.8m, $71.5m was the repayment of the loan it had made to OPTN and $11.3m came as ‘make-whole’ and prepayment fees, and accrued interest. There is another $1.6m to come in connection with the company’s …
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
